New Migraine Medication

The Food and Drug Administration has approved lasmiditan (Reyvow), a new treatment for acute migraine.Patients must avoid driving or other activities requiring full mental alertness, such as operating heavy machinery, for a minimum of eight hours after taking lasmiditan.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research